http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5965743-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7962109cd4763907b82b66760cd0ae8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00 |
| filingDate | 1996-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec318f0144c8a76a74d0197dfa35bea7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53234c104b02ded25f74599fe4d5fa0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91bf4366d4ae7df449a7fb940be84364 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16b76d25c574d6a88a82b1bb121d11c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9588a9313e1555048eaef71894d29a6e |
| publicationDate | 1999-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5965743-A |
| titleOfInvention | N-substituted imidazol derivative |
| abstract | PCT No. PCT/JP95/00827 Sec. 371 Date Mar. 3, 1997 Sec. 102(e) Date Mar. 3, 1997 PCT Filed Apr. 26, 1996 PCT Pub. No. WO95/29163 PCT Pub. Date Nov. 2, 1995The present invention is to provide novel imidazole derivatives effectual as an antihyperlipemic agent and therapeutic and preventive drugs for arteriosclerosis, and to provide methods for manufacturing the said derivatives. More particularly, the present invention is directed to the compounds represented by the following general formula [I]; wherein R1 is hydrogen or lower alkyl, n is 0 or 1, X is N-r1 wherein r1 is hydrogen or lower alkyl, O, S, SO, SO2, CH2, CH(CH3), CONH or C(r2)=NO wherein r2 is hydrogen or lower alkyl, m is 0 or an integer of from 1 to 12, and A is methyl or a group represented by the following general formula; wherein Y is N-r3 wherein r3 is hydrogen or lower alkyl, N(r4)SO2 wherein r4 is hydrogen or lower alkyl, O, S, SO, SO2, CH2, CH(CH3), CONH or C(r5)=NO wherein r5 is hydrogen or lower alkyl, R2 is a halogen, a lower alkyl, a lower alkoxy, a cycloalkyl or COOr6 wherein r6 is hydrogen or a lower alkyl, and l is 0, 1, 2 or 3, however, m denotes an integer of from 6 to 9 when A is methyl, or m denotes 0 or an integer of from 1 to 6 when A is a group represented by the following general formula; and X and Y are each independently CH2 when m is 0, the pharmaceutically-acceptable salts thereof and methods for manufacturing the said compounds and the pharmaceutically-acceptable salts thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9079864-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012129906-A1 |
| priorityDate | 1994-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 430.